Login / Signup

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy.

Isabelle J PouliquenP HowarthD AustinG GunnE MeyerR G PriceE Bradford
Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2017)
Keyphrases
  • low dose
  • case report
  • chronic obstructive pulmonary disease
  • high dose
  • multiple sclerosis
  • lung function
  • drug induced
  • early onset
  • allergic rhinitis
  • bone marrow